Skip to content
PICO Portalanswers from OpenAlex

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study

PaperCitations, authors & open-access status

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study is a paper indexed in PICO Portal from OpenAlex.

How many citations does The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study have?

PICO Portalcitation count

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study has 99 citations in the OpenAlex counts PICO Portal stores.

When was The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study published?

PICO Portalyear

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study has 2020 year in the PICO Portal index.

What is the open-access status of The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study?

PICO Portaloa status

The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study has green oa status in the PICO Portal index.

What is the DOI of The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study?

PICO Portaldoi

The DOI for The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study is on the source record.

What is the OpenAlex record for The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study?

PICO Portalopenalex

The OpenAlex for The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial